• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

来自儿科肺动脉高压网络的儿科皮下曲前列尼尔部位维护及疼痛控制策略

Pediatric subcutaneous treprostinil site maintenance and pain control strategies from the Pediatric Pulmonary Hypertension Network.

作者信息

Jackson Emma O, Brown Anna, McSweeney Julia, Parker Claire

机构信息

Department of Cardiology, Seattle Children's Hospital, Seattle, WA, USA.

Division of Pulmonary Medicine, Department of Pediatrics, Vanderbilt Children's Hospital, Nashville, TN, USA.

出版信息

Pulm Circ. 2021 Mar 2;11(1):2045894021994450. doi: 10.1177/2045894021994450. eCollection 2021 Jan-Mar.

DOI:10.1177/2045894021994450
PMID:33738093
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7934043/
Abstract

Pulmonary arterial hypertension is a chronic, progressive, and life-threatening disease in children with diverse causes of pulmonary arterial hypertension. The most severe cases of pulmonary arterial hypertension require aggressive treatments with systemic administration of continuous prostacyclin therapy, including treprostinil and epoprostenol. The successful use of continuous subcutaneous treprostinil therapy eliminates the need for an indwelling central venous catheter and its associated risks. However, pain at the subcutaneous infusion site, an expected side effect of this therapy, is often a deterrent to its widespread use. Effective subcutaneous treprostinil site maintenance and pain management is essential to achieve success with this therapy, but strategies surrounding site maintenance and pain control vary significantly between pediatric pulmonary hypertension treatment centers. In an attempt to standardize practice, a survey on the use of subcutaneous treprostinil and site maintenance and pain management strategies, as well as its perceived effectiveness, was disseminated to 13 pediatric pulmonary hypertension centers of the Pediatric Pulmonary Hypertension Network. Responses to the survey were collected and analyzed and were developed into a set of formalized strategies to facilitate knowledge sharing and standardization of practice.

摘要

肺动脉高压是一种发生于儿童的慢性、进行性且危及生命的疾病,其肺动脉高压病因多样。最严重的肺动脉高压病例需要采用积极的治疗方法,即持续静脉输注前列环素类药物进行全身治疗,包括曲前列尼尔和依前列醇。成功使用皮下持续输注曲前列尼尔疗法可避免使用中心静脉留置导管及其相关风险。然而,皮下输注部位疼痛是该疗法的一个预期副作用,这常常阻碍其广泛应用。有效的皮下曲前列尼尔输注部位护理和疼痛管理对于该疗法的成功实施至关重要,但在儿科肺动脉高压治疗中心,围绕输注部位护理和疼痛控制的策略差异很大。为了规范实践,一项关于皮下曲前列尼尔的使用、输注部位护理和疼痛管理策略及其感知效果的调查被分发给了儿科肺动脉高压网络的13个儿科肺动脉高压中心。对调查的回复进行了收集和分析,并制定了一套正式策略,以促进知识共享和实践标准化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3747/7934043/a348cdfa49f5/10.1177_2045894021994450-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3747/7934043/e98fa5ed6b3d/10.1177_2045894021994450-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3747/7934043/1d8e5e7fe28d/10.1177_2045894021994450-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3747/7934043/a348cdfa49f5/10.1177_2045894021994450-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3747/7934043/e98fa5ed6b3d/10.1177_2045894021994450-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3747/7934043/1d8e5e7fe28d/10.1177_2045894021994450-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3747/7934043/a348cdfa49f5/10.1177_2045894021994450-fig3.jpg

相似文献

1
Pediatric subcutaneous treprostinil site maintenance and pain control strategies from the Pediatric Pulmonary Hypertension Network.来自儿科肺动脉高压网络的儿科皮下曲前列尼尔部位维护及疼痛控制策略
Pulm Circ. 2021 Mar 2;11(1):2045894021994450. doi: 10.1177/2045894021994450. eCollection 2021 Jan-Mar.
2
Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial.前列环素类似物曲前列尼尔持续皮下输注治疗肺动脉高压患者:一项双盲、随机、安慰剂对照试验。
Am J Respir Crit Care Med. 2002 Mar 15;165(6):800-4. doi: 10.1164/ajrccm.165.6.2106079.
3
Safety, efficacy and Management of subcutaneous treprostinil infusions in the treatment of severe pediatric pulmonary hypertension.在治疗严重小儿肺动脉高压中皮下注射曲前列尼尔的安全性、疗效和管理。
Int J Cardiol. 2018 Aug 1;264:153-157. doi: 10.1016/j.ijcard.2018.03.067. Epub 2018 Mar 15.
4
Transitioning from i.v. epoprostenol to subcutaneous treprostinil in pulmonary arterial hypertension.肺动脉高压患者从静脉注射依前列醇转换为皮下注射曲前列尼尔的治疗转换
Chest. 2002 May;121(5):1561-5. doi: 10.1378/chest.121.5.1561.
5
Failure to tolerate continuous subcutaneous treprostinil in pediatric pulmonary hypertension patients.小儿肺动脉高压患者无法耐受持续皮下注射曲前列尼尔。
Pulm Circ. 2023 Apr 1;13(2):e12224. doi: 10.1002/pul2.12224. eCollection 2023 Apr.
6
Use of subcutaneous treprostinil in pediatric pulmonary arterial hypertension-Bridge-to-transplant or long-term treatment?皮下注射曲前列尼尔在儿童肺动脉高压中的应用——过渡到移植还是长期治疗?
Pediatr Transplant. 2018 Mar;22(2). doi: 10.1111/petr.13106. Epub 2017 Dec 19.
7
Case report: Stepwise transition from subcutaneous treprostinil to epoprostenol in high-risk pulmonary arterial hypertension.病例报告:高危肺动脉高压患者从皮下注射曲前列尼尔逐步过渡至依前列醇治疗
Eur Heart J Case Rep. 2021 Oct 22;5(10):ytaa578. doi: 10.1093/ehjcr/ytaa578. eCollection 2021 Oct.
8
Treprostinil for pulmonary hypertension.曲前列尼尔用于治疗肺动脉高压。
Vasc Health Risk Manag. 2008;4(3):507-13. doi: 10.2147/vhrm.s2477.
9
The role of treprostinil in the management of pulmonary hypertension.曲前列尼尔在肺动脉高压管理中的作用。
Am J Cardiovasc Drugs. 2008;8(4):213-7. doi: 10.2165/00129784-200808040-00001.
10
Transition from intravenous or subcutaneous prostacyclin therapy to inhaled treprostinil in patients with pulmonary arterial hypertension: a retrospective case series.肺动脉高压患者从静脉或皮下前列环素治疗转换为吸入曲前列尼尔治疗:一项回顾性病例系列研究
J Clin Pharm Ther. 2014 Oct;39(5):496-500. doi: 10.1111/jcpt.12170. Epub 2014 May 8.

引用本文的文献

1
Cannabidiol (CBD) for the treatment of subcutaneous treprostinil (Remodulin) site pain: a case report.大麻二酚(CBD)用于治疗皮下曲前列尼尔(瑞莫杜林)注射部位疼痛:一例报告
Front Med (Lausanne). 2023 Jun 13;10:1188083. doi: 10.3389/fmed.2023.1188083. eCollection 2023.
2
Failure to tolerate continuous subcutaneous treprostinil in pediatric pulmonary hypertension patients.小儿肺动脉高压患者无法耐受持续皮下注射曲前列尼尔。
Pulm Circ. 2023 Apr 1;13(2):e12224. doi: 10.1002/pul2.12224. eCollection 2023 Apr.
3
Pharmacokinetics of treprostinil in children with functional single-ventricle pulmonary arterial hypertension: a randomized controlled trial.

本文引用的文献

1
Safety, efficacy and Management of subcutaneous treprostinil infusions in the treatment of severe pediatric pulmonary hypertension.在治疗严重小儿肺动脉高压中皮下注射曲前列尼尔的安全性、疗效和管理。
Int J Cardiol. 2018 Aug 1;264:153-157. doi: 10.1016/j.ijcard.2018.03.067. Epub 2018 Mar 15.
2
Pediatric Pulmonary Hypertension: Guidelines From the American Heart Association and American Thoracic Society.儿童肺动脉高压:美国心脏协会和美国胸科学会指南。
Circulation. 2015 Nov 24;132(21):2037-99. doi: 10.1161/CIR.0000000000000329. Epub 2015 Nov 3.
3
Central venous line complications with chronic ambulatory infusion of prostacyclin analogues in pediatric patients with pulmonary arterial hypertension.
曲前列尼尔在功能性单心室肺动脉高压患儿中的药代动力学:一项随机对照试验。
Ann Transl Med. 2021 Jul;9(14):1163. doi: 10.21037/atm-21-3188.
在患有肺动脉高压的儿科患者中,长期门诊输注前列环素类似物的中心静脉导管并发症
Pulm Circ. 2015 Jun;5(2):322-326. doi: 10.1086/680215.
4
Subcutaneous treprostinil in pulmonary arterial hypertension: Practical considerations.皮下注射曲前列尼尔治疗肺动脉高压:实际考虑。
J Heart Lung Transplant. 2010 Nov;29(11):1210-7. doi: 10.1016/j.healun.2010.06.013. Epub 2010 Sep 19.
5
Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.研究电子数据采集(REDCap)——一种用于提供转化研究信息学支持的元数据驱动方法和工作流程。
J Biomed Inform. 2009 Apr;42(2):377-81. doi: 10.1016/j.jbi.2008.08.010. Epub 2008 Sep 30.